RNA-seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus

Abstract

Background

Circular RNAs (circRNAs) are possible biomarkers for many diseases, but the knowledge of circRNAs in the peripheral blood mononuclear cells (PBMCs) of patients with systemic lupus erythematosus (SLE) remains limited. This study aimed to assess the expression of circRNAs in PBMCs from patients with SLE and healthy individuals by RNA sequencing (RNA-seq).

Methods

In total, 128 circRNAs were significantly differentially expressed including 39 upregulated and 89 downregulated circRNAs in four new-onset SLE patients compared with three healthy controls. After verification of the four candidate circRNAs in 49 patients with SLE and 37 controls using quantitative real-time polymerase chain reaction (qRT-PCR) assays, a previously undescribed circRNA with potential translation activity, circPTPN22, was selected to confirm its clinical significance.

Results

Bioinformatics analysis demonstrated that the parent gene of circPTPN22 was protein tyrosine phosphatase non-receptor type 22 (PTPN22), a potent regulator of T cell activation. The downregulation of circPTPN22 in patients with SLE was strongly negatively correlated with their Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores. circRNA-miRNA-mRNA co-expression network analysis indicated a correlation between circPTPN22 and the miRNAs and mRNAs related to immunological regulation including the development of SLE. Patients with higher SLEDAI scores had lower circPTPN22 expression levels, and long-term hormone treatment significantly increased circPTPN22 levels. Receiver operating characteristic curve analysis indicated that circPTPN22 has good diagnostic value for SLE.

Conclusion

Our data demonstrated the aberrant expression of circRNAs in patients with SLE compared with healthy controls; circPTPN22 might function as a diagnostic and disease severity indicator in SLE.

Keywords

Circular RNA miRNA systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Deng

Tsokos

. Pathogenesis and targeted treatment of skin injury in SLE. Nat Rev Rheumatol 2015; 11: 663–669.

Hanly

. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol 2014; 10: 338–347.

Touma

Gladman

. Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments. Lupus Sci Med 2017; 4: e000239.

Mohan

Putterman

. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 2015; 11: 329–341.

Ceccarelli

Perricone

Massaro

et al.

Assessment of disease activity in systemic lupus erythematosus: lights and shadows. Autoimmun Rev 2015; 14: 601–608.

Hentze

Preiss

. Circular RNAs: splicing's enigma variations. EMBO J 2013; 32: 923–925.

Lasda

Parker

. Circular RNAs: diversity of form and function. RNA 2014; 20: 1829–1842.

Zhu

Zhao

et al.

Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus. Immunology 2018; 155: 137–149.

Lai

et al.

Comprehensive circular RNA profiles in plasma reveals that circular RNAs can be used as novel biomarkers for systemic lupus erythematosus. Clin Chim Acta 2018; 480: 17–25.

10.

Bottini

Peterson

. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu Rev Immunol 2014; 32: 83–119.

11.

Chung

Criswell

. PTPN22: its role in SLE and autoimmunity. Autoimmunity 2007; 40: 582–590.

12.

Zheng

Petersen

. The role of PTPN22 in autoimmunity: learning from mice. Autoimmun Rev 2014; 13: 266–271.

13.

Glazar

Papavasileiou

Rajewsky

. circBase: a database for circular RNAs. RNA 2014; 20: 1666–1670.

14.

Zarate-Neira

Sanchez-Barbosa

Pedroza-Torres

et al.

Dysregulation of miR-155-5p and miR-200-3p and the anti-non-bilayer phospholipid arrangement antibodies favor the development of lupus in three novel murine lupus models. J Immunol Res 2017; 2017: 8751642.

15.

Wang

Wen

Zhang

et al.

Interleukin-7 receptor single nucleotide polymorphism rs6897932 (C/T) and the susceptibility to systemic lupus erythematosus. Inflammation 2014; 37: 615–620.

16.

Mende

Vincent

Kandane-Rathnayake

et al.

Analysis of serum interleukin (IL)-1beta and IL-18 in systemic lupus erythematosus. Front Immunol 2018; 9: 1250.

17.

Deng

Huang

Zhou

et al.

Gene profiling involved in immature CD4 + T lymphocyte responsible for systemic lupus erythematosus. Mol Immunol 2006; 43: 1497–1507.

18.

Elghzaly

Metwally

El-Chennawi

et al.

IRF5, PTPN22, CD28, IL2RA, KIF5A, BLK and TNFAIP3 genes polymorphisms and lupus susceptibility in a cohort from the Egypt Delta; relation to other ethnic groups. Hum Immunol 2015; 76: 525–531.

19.

Zhang

Xin

. Circular RNAs: a new frontier for cancer diagnosis and therapy. J Hematol Oncol 2018; 11: 21.

20.

Wang

Cui

Zhao

et al.

Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma. Cancer Biomark 2018; 22: 631–640.

21.

Cui

Niu

Kong

et al.

hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in major depressive disorder. Biomark Med 2016; 10: 943–952.

22.

Sun

Tang

Rong

et al.

Hsa_circ_0000520, a potential new circular RNA biomarker, is involved in gastric carcinoma. Cancer Biomark 2018; 21: 299–306.

23.

Xie

Shao

Sun

et al.

Downregulated expression of hsa_circ_0074362 in gastric cancer and its potential diagnostic values. Biomark Med 2018; 12: 11–20.

24.

Zheng

Huang

et al.

Circular RNA expression profiles of peripheral blood mononuclear cells in rheumatoid arthritis patients, based on microarray chip technology. Mol Med Rep 2017; 16: 8029–8036.

25.

Ouyang

Jiang

et al.

Microarray expression profile of circular RNAs in peripheral blood mononuclear cells from rheumatoid arthritis patients. Cell Physiol Biochem 2017; 42: 651–659.

26.

Iparraguirre

Munoz-Culla

Prada-Luengo

et al.

Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis. Hum Mol Genet 2017; 26: 3564–3572.

27.

Lei

Bai

Wei

et al.

The mechanism and function of circular RNAs in human diseases. Exp Cell Res 2018; 368: 147–158.

28.

Zhong

Yang

et al.

Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer 2018; 17: 79.

29.

Wilusz

. A 360 degrees view of circular RNAs: from biogenesis to functions. Wiley Interdiscip Rev RNA 2018; 9: e1478.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB